New procedure aims to stop Liver-Related confusion by blocking rogue blood vessels
NCT ID NCT07553858
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new procedure that uses an endoscope (a thin tube with a camera) to guide coils and glue into abnormal blood vessels in the liver. The goal is to block these vessels and reduce severe confusion (hepatic encephalopathy) in people with liver cirrhosis. The trial will include 34 adults who have not improved with standard medications. Participants will either receive the procedure or continue medical management, and their confusion levels will be tracked for four weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Endoscopic ultrasound-guided embolization (a procedure using coils and glue to block abnormal blood vessels)
What this could lead to
If it works, this could offer a new treatment option for people with severe confusion from liver disease that doesn't improve with standard medications.
What could go wrong
This is a very small, early-stage trial with only 34 participants. The procedure is new and carries risks like bleeding or infection. It may not work better than current treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rutgers University Hospital
Newark, New Jersey, 07103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact